Difference between revisions of "Template:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Final thoughts and additional resources/Key guidance documents"

From LIMSWiki
Jump to navigationJump to search
(Updated for August)
(November updates)
Line 1: Line 1:
===5.2 Key guidance documents===
===5.2 Key guidance documents===


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html |title=How to Report COVID-19 Laboratory Data |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 August 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html |title=Guidance for SARS-CoV-2 Point-of-Care Testing |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=20 November 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=08 July 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html |title=How to Report COVID-19 Laboratory Data |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=02 November 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=11 August 2020}}
* {{cite web |url=https://www.cdc.gov/nchs/data/icd/10cmguidelines-FY2021.pdf |format=PDF |title=ICD-10-CM Official Guidelines for Coding and Reporting - FY 2021 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=01 October 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 July 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=05 November 2020}}
 
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=19 September 2020}}
 
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=21 October 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf |title=Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 May 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf |title=Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 May 2020}}
* {{cite web |url=https://ec.europa.eu/commission/presscorner/detail/en/QANDA_20_1905 |title=Coronavirus: EU interoperability gateway for contact tracing and warning apps – Questions and Answers |author=European Commission  |publisher=European Union |date=19 October 2020}}


* {{cite web |url=https://edpb.europa.eu/sites/edpb/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf |format=PDF |title=Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak |author=European Data Protection Board |publisher=European Union |date=April 2020}}
* {{cite web |url=https://edpb.europa.eu/sites/edpb/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf |format=PDF |title=Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak |author=European Data Protection Board |publisher=European Union |date=April 2020}}
Line 19: Line 25:
* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=16 July 2020}}
* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=16 July 2020}}


* {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=13 August 2020}}
* {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=12 November 2020}}


* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=May 2020}}
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=May 2020}}
Line 26: Line 32:


* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}}
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}}
* {{cite web |url=https://apps.who.int/iris/handle/10665/335843 |title=Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim guidance, 2 October 2020 |work=WHO/2019-nCoV/Lab_Assessment_Tool/2020.2 |author=World Health Organization, et al. |publisher=World Health Organization |date=02 October 2020}}
* {{cite web |url=https://apps.who.int/iris/handle/10665/334254 |title=Diagnostic testing for SARS-CoV-2: Interim guidance, 11 September 2020 |work=WHO/2019-nCoV/laboratory/2020.6 |author=World Health Organization, et al. |publisher=World Health Organization |date=11 September 2020}}


* {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}}
* {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}}
* {{cite web |url=https://apps.who.int/iris/handle/10665/331501 |title=Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020 |work=WHO/COVID-19/laboratory/2020.5 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}

Revision as of 18:45, 21 November 2020

5.2 Key guidance documents